# Melanoma trials recruiting, no drug phase: 82 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 82 trials with no drug phase for melanoma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting melanoma trials with no drug phase: 82 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/melanoma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 82
- Recruiting or not yet: 82
- Read on: November 19, 2026

## Trials

The 25 newest of 82, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07940036 | Skin Cancer Detection in Primary Care With and Without DermaSensor | DermaSensor, Inc. | Not applicable | Not yet recruiting | Skin Cancer, Basal Cell Cancer, Squamous Cell Carcinoma, Melanoma (Skin Cancer), Melanoma In Situ, Melanoma Detection... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940036) |
| October 13, 2026 | NCT07870265 | Detection of the BRAF V600E Mutation in Liquid Biopsy Using the CRISPR/Cas12a System | Masaryk Memorial Cancer Institute | Not applicable | Recruiting | Unresectable Metastatic Melanoma | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07870265) |
| October 9, 2026 | NCT07869381 | Trial Comparing CPDMA Versus Standard Breadloafing in WLE Specimens of Stage 1-II Cutaneous Melanoma | University of Nebraska | Not applicable | Not yet recruiting | Cutaneous Melanoma, Stage II, Cutaneous Melanoma, Acral Melanoma | 282 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869381) |
| October 9, 2026 | NCT07869186 | Dermatological Effects and Quality of Life in Oncology Patients | European Institute of Oncology | Not applicable | Not yet recruiting | Breast Cancer, Ovarian Cancer, NSCLC (Non-small Cell Lung Cancer), Melanoma (Skin Cancer), Gynecological Cancer | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869186) |
| September 21, 2026 | NCT07830225 | A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma. | Rutgers, The State University of New Jersey | Not applicable | Recruiting | Melanoma (Skin Cancer) | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07830225) |
| September 11, 2026 | NCT07815873 | Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers | European Institute of Oncology | Not applicable | Not yet recruiting | Non Small Cell Lung Cancer, Melanoma (Skin Cancer), Endometrial Cancer, Cervical Cancer | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07815873) |
| August 26, 2026 | NCT07788729 | Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons | University of Regensburg | Not applicable | Recruiting | Cancer, Lung Cancer, Colorectal Cancer, Hematological Cancer, Malignant Melanoma | 384 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07788729) |
| August 12, 2026 | NCT07761871 | Exercise and Nutritional Intervention in Patients With Melanoma Receiving Immunotherapy | Institute of Oncology Ljubljana | Not applicable | Not yet recruiting | Melanoma | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761871) |
| August 12, 2026 | NCT07760012 | 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors | Peking University Third Hospital | Not applicable | Recruiting | Melanoma (Skin Cancer), Hepatocellular Carcinoma, Lung Cancer, Breast Cancer, Pancreatic Cancer, Ovarian Cancer... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07760012) |
| July 31, 2026 | NCT07740642 | A Comparative Usability Study of Two Total Body Skin Imaging Systems | University Hospital, Basel, Switzerland | Not applicable | Not yet recruiting | Melanoma (Skin Cancer) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07740642) |
| July 15, 2026 | NCT07704918 | Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma | University of Colorado, Denver | Not applicable | Recruiting | Melanoma | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704918) |
| July 10, 2026 | NCT07696715 | Timing of Immunotherapy in Melanoma | Radboud University Medical Center | Not applicable | Recruiting | Melanoma | 170 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07696715) |
| July 8, 2026 | NCT07689812 | A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI)... | Natera, Inc. | Not applicable | Not yet recruiting | NSCLC (Advanced Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Carcinoma)... | 920 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07689812) |
| July 2, 2026 | NCT07680452 | Clinical Study on High-fiber Diet and Short-term Fasting in Melanoma Under Immunotherapy With Checkpoint Inhibition | Charite University, Berlin, Germany | Not applicable | Recruiting | Melanoma (Skin Cancer) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07680452) |
| June 22, 2026 | NCT07661966 | Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade | Weill Medical College of Cornell University | Not applicable | Recruiting | Melanoma (Skin Cancer), NSCLC (Non-small Cell Lung Cancer) | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07661966) |
| June 22, 2026 | NCT07660666 | Feasibility of an Enhanced Symptom Monitoring and Expedited Subspecialty Care Referral Intervention to Improve Side Effect Management for... | OHSU Knight Cancer Institute | Not applicable | Not yet recruiting | Melanoma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07660666) |
| June 17, 2026 | NCT07653087 | Evaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk Melanoma | University of Virginia | Not applicable | Not yet recruiting | Sentinel Lymph Node Biopsy (SLNB), Melanoma (Skin Cancer) | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07653087) |
| June 16, 2026 | NCT07649681 | Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention | Wuerzburg University Hospital | Not applicable | Recruiting | Multiple Myeloma (MM), GI Cancer, Taste Disorder, Melanoma (Skin Cancer), Urogenital Cancers | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07649681) |
| June 12, 2026 | NCT07645742 | Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors | West Virginia University | Not applicable | Not yet recruiting | Cancer (Advanced Stage) | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07645742) |
| May 14, 2026 | NCT07586891 | Exploratory Study With Parallel Controls on the Safety and Efficacy of Neoadjuvant Low Branched-Chain Amino Acid Diet in Combination With... | Xijing Hospital | Not applicable | Recruiting | Melanoma (Skin Cancer) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07586891) |
| May 4, 2026 | NCT07564570 | Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma | Universitätsklinikum Hamburg-Eppendorf | Not applicable | Recruiting | Metastatic Melanoma | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07564570) |
| April 29, 2026 | NCT07555210 | Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy | Sponsor not shown (see the record) | Not applicable | Recruiting | Breast Cancer (Triple Negative Breast Cancer (TNBC)), Renal Cell Carcinoma (Kidney Cancer), Melanoma (Skin Cancer)... | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07555210) |
| April 14, 2026 | NCT07529080 | Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer... | University of Michigan Rogel Cancer Center | Not applicable | Not yet recruiting | Differentiated Thyroid Gland Carcinoma, Malignant Testicular Neoplasm, Melanoma, Thyroid Gland Follicular Carcinoma... | 142 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07529080) |
| February 20, 2026 | NCT07422779 | Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia | Institute of Oncology Ljubljana | Not applicable | Recruiting | Metastatic Melanoma, Skin Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07422779) |
| February 12, 2026 | NCT07407166 | Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers | Institute of Oncology Ljubljana | Not applicable | Recruiting | Metastatic Melanoma, Melanoma | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07407166) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Institute of Oncology Ljubljana | 4 |
| Hospices Civils de Lyon | 3 |
| M.D. Anderson Cancer Center | 3 |
| Centre Hospitalier Universitaire de Nice | 3 |
| Erasmus Medical Center | 2 |
| Xijing Hospital | 2 |
| European Institute of Oncology | 2 |
| DermaSensor, Inc. | 2 |
| Rutgers, The State University of New Jersey | 2 |
| Wuerzburg University Hospital | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Massachusetts General Hospital | 1 |
| University of Regensburg | 1 |
| West Virginia University | 1 |
| Leiden University Medical Center | 1 |
| OHSU Knight Cancer Institute | 1 |
| University of Aarhus | 1 |
| Radboud University Medical Center | 1 |
| Melanoma Institute Australia | 1 |
| CNAO National Center of Oncological Hadrontherapy | 1 |
| University Medical Center Groningen | 1 |
| Goethe University | 1 |
| University of Utah | 1 |
| Peter MacCallum Cancer Centre, Australia | 1 |
| Uppsala University | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 29 |
| France | 11 |
| Italy | 9 |
| Germany | 8 |
| Netherlands | 7 |
| Slovenia | 5 |
| Sweden | 4 |
| Australia | 3 |
| Canada | 3 |
| United Kingdom | 3 |
| Denmark | 2 |
| China | 2 |
| Czechia | 2 |
| Switzerland | 2 |
| Israel | 1 |
| Ireland | 1 |
| New Zealand | 1 |
| Spain | 1 |
| Belgium | 1 |
| Poland | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Arabian restaurants in the United States](https://specstream.ai/data/businesses/arabian-restaurants/united-states)
- [Cleaning companies in the United States](https://specstream.ai/data/businesses/cleaning-companies/united-states)
- [Flight schools in the United States](https://specstream.ai/data/businesses/flight-schools/united-states)
- [Life insurance agencies in the United States](https://specstream.ai/data/businesses/life-insurance-agencies/united-states)
- [Pressure washing companies in the United States](https://specstream.ai/data/businesses/pressure-washing-companies/united-states)
- [Tools wholesalers in the United States](https://specstream.ai/data/businesses/tools-wholesalers/united-states)
